Sharon Smith

Using LDIR, O PTIR, Py GC/MS, and SEM, researchers quantified MNPs in 191 brain samples, but experts question the unusually high particle masses and urge methodological validation. Medscape News Europe source https://www.medscape.com/viewarticle/study-finds-microplastics-near-tumors-experts-doubt-results-2026a1000ea7?src=rss

As new tech and changing norms drive fatigue mitigation, the moment is ripe to prioritize patient safety (and yours) by recognizing when you’re too tired to operate — and speaking up. Medscape Medical News source https://www.medscape.com/viewarticle/fatigue-finally-surgical-safety-issue-2026a1000e9w?src=rss

New data show strong links between chronic disease, sexual dysfunction, and loneliness, highlighting missed opportunities for holistic patient evaluation. Medscape News Europe source https://www.medscape.com/viewarticle/missed-sexual-health-assessment-may-limit-clinical-insight-2026a1000e4i?src=rss

The Baveno VI criteria show high sensitivity for ruling out clinically significant portal hypertension and high-risk varices in patients with cirrhosis. Medscape Medical News source https://www.medscape.com/viewarticle/baveno-criteria-may-reduce-endoscopy-burden-patients-2026a1000e40?src=rss

RFK Jr and Joe Rogan use them to heal, and NASA wants to put one in the astropharmacy. But without extensive data on humans, what should you tell patients about peptides? Medscape Medical News source https://www.medscape.com/viewarticle/gray-market-peptides-so-much-hype-so-little-data-2026a1000dzg?src=rss

The FDA has approved Auvelity for AD agitation. The combination of dextromethorphan and bupropion is the first oral non-antipsychotic approved for this indication. Medscape Medical News source https://www.medscape.com/viewarticle/fda-oks-first-non-antipsychotic-alzheimers-agitation-2026a1000dze?src=rss